US Stock MarketDetailed Quotes
ABUS Arbutus Biopharma
- 4.110
- +0.250+6.48%
Close Oct 15 16:00 ET
- 4.107
- -0.003-0.07%
Post 17:04 ET
775.89MMarket Cap-9133P/E (TTM)
4.120High3.890Low1.17MVolume3.910Open3.860Pre Close4.75MTurnover0.87%Turnover RatioLossP/E (Static)188.78MShares4.72552wk High6.33P/B556.94MFloat Cap1.69052wk Low--Dividend TTM135.51MShs Float31.480Historical High--Div YieldTTM5.96%Amplitude0.821Historical Low4.054Avg Price1Lot Size
Arbutus Biopharma Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -6.88%141.99M | -11.92%129.24M | -14.23%126M | -14.23%126M | -0.40%134.18M | 1.52%152.48M | -11.33%146.73M | -5.41%146.91M | -5.41%146.91M | 10.97%134.72M |
| -Cash and cash equivalents | 130.86%62.79M | 6.23%43.1M | -14.59%26.29M | -14.59%26.29M | -26.97%17.53M | -42.53%27.2M | -50.11%40.57M | -71.84%30.78M | -71.84%30.78M | -69.18%24M |
| -Short-term investments | -36.79%79.2M | -18.85%86.14M | -14.14%99.72M | -14.14%99.72M | 5.36%116.65M | 21.78%125.29M | 26.15%106.15M | 152.28%116.14M | 152.28%116.14M | 154.40%110.71M |
| Receivables | -32.40%1.77M | -19.71%2.14M | 31.36%1.78M | 31.36%1.78M | 18.31%2.17M | 32.69%2.61M | 102.89%2.66M | 50.39%1.35M | 50.39%1.35M | 10.08%1.84M |
| -Accounts receivable | -32.40%1.77M | -19.71%2.14M | 31.36%1.78M | 31.36%1.78M | 18.31%2.17M | 32.69%2.61M | 102.89%2.66M | 50.39%1.35M | 50.39%1.35M | 10.08%1.84M |
| Prepaid assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 32.23%4.58M |
| Other current assets | 20.66%4.47M | 29.78%4.49M | 47.81%4.25M | 47.81%4.25M | --5.26M | --3.7M | --3.46M | -35.34%2.87M | -35.34%2.87M | ---- |
| Total current assets | -6.66%148.22M | -11.11%135.87M | -12.65%132.03M | -12.65%132.03M | 0.33%141.61M | 0.64%158.8M | -11.49%152.85M | -5.93%151.14M | -5.93%151.14M | 11.54%141.14M |
| Non current assets | ||||||||||
| Net PPE | -23.85%5.3M | -11.92%5.74M | -10.63%6.09M | -10.63%6.09M | -7.46%6.54M | -6.20%6.96M | -15.03%6.52M | -15.62%6.81M | -15.62%6.81M | -17.17%7.06M |
| -Gross PPE | -2.85%17.91M | 1.95%18M | 2.13%17.99M | 2.13%17.99M | 3.07%18.08M | 5.04%18.43M | 1.23%17.65M | 0.95%17.62M | 0.95%17.62M | 0.37%17.54M |
| -Accumulated depreciation | -9.88%-12.61M | -10.07%-12.26M | -10.17%-11.9M | -10.17%-11.9M | -10.18%-11.54M | -13.27%-11.48M | -13.99%-11.14M | -15.22%-10.8M | -15.22%-10.8M | -17.09%-10.48M |
| Investments and advances | -40.97%6.53M | -72.71%8.68M | -83.18%6.28M | -83.18%6.28M | -81.07%10.5M | -78.08%11.06M | -43.55%31.79M | 4.69%37.36M | 4.69%37.36M | 81.55%55.44M |
| Other non current assets | ---- | ---- | ---- | ---- | -98.20%3K | -93.89%11K | -67.37%62K | 68.85%103K | 68.85%103K | --167K |
| Total non current assets | -34.40%11.82M | -62.42%14.42M | -72.06%12.37M | -72.06%12.37M | -72.82%17.03M | -68.95%18.02M | -40.21%38.37M | 1.04%44.28M | 1.04%44.28M | 60.43%62.67M |
| Total assets | -9.49%160.04M | -21.41%150.29M | -26.11%144.4M | -26.11%144.4M | -22.16%158.64M | -18.08%176.82M | -19.27%191.22M | -4.43%195.42M | -4.43%195.42M | 23.07%203.8M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 154.02%2.65M | 52.46%3.74M | -8.44%3.22M | -8.44%3.22M | 159.17%2.26M | --1.04M | 105.61%2.46M | 10.90%3.52M | 10.90%3.52M | -16.31%872K |
| -accounts payable | 154.02%2.65M | 52.46%3.74M | -8.44%3.22M | -8.44%3.22M | 159.17%2.26M | --1.04M | 105.61%2.46M | 10.90%3.52M | 10.90%3.52M | -16.31%872K |
| Current accrued expenses | 8.96%8.46M | -37.43%4.5M | -43.66%7.05M | -43.66%7.05M | -33.78%7.55M | -37.78%7.76M | -4.29%7.2M | 63.22%12.51M | 63.22%12.51M | 31.78%11.4M |
| Current debt and capital lease obligation | 14.11%453K | 12.56%502K | 14.25%425K | 14.25%425K | 14.44%412K | 5.31%397K | 1.59%446K | -2.87%372K | -2.87%372K | -6.74%360K |
| -Current capital lease obligation | 14.11%453K | 12.56%502K | 14.25%425K | 14.25%425K | 14.44%412K | 5.31%397K | 1.59%446K | -2.87%372K | -2.87%372K | -6.74%360K |
| Current deferred liabilities | -28.01%11.03M | -23.30%11.55M | -28.35%11.79M | -28.35%11.79M | -18.63%12.11M | -9.70%15.33M | -35.26%15.06M | --16.46M | --16.46M | --14.88M |
| Current liabilities | -7.88%22.6M | -19.31%20.3M | -31.56%22.49M | -31.56%22.49M | -18.84%22.32M | -17.75%24.53M | -22.39%25.15M | 192.82%32.86M | 192.82%32.86M | 171.99%27.51M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -30.50%1.14M | -29.32%1.18M | -26.01%1.34M | -26.01%1.34M | -23.43%1.5M | -21.17%1.65M | -20.43%1.67M | -18.65%1.82M | -18.65%1.82M | -16.99%1.96M |
| -Long term capital lease obligation | -30.50%1.14M | -29.32%1.18M | -26.01%1.34M | -26.01%1.34M | -23.43%1.5M | -21.17%1.65M | -20.43%1.67M | -18.65%1.82M | -18.65%1.82M | -16.99%1.96M |
| Non current deferred liabilities | ---- | ---- | --0 | --0 | --0 | --0 | -78.85%3.3M | --6M | --6M | --10.59M |
| Other non current liabilities | -13.19%13.85M | -17.52%14.18M | -18.68%14.55M | -18.68%14.55M | -15.11%15.48M | -19.98%15.96M | -17.91%17.19M | -17.13%17.9M | -17.13%17.9M | -20.66%18.24M |
| Total non current liabilities | -14.81%14.99M | -30.68%15.36M | -38.17%15.9M | -38.17%15.9M | -44.83%16.98M | -46.45%17.6M | -42.64%22.16M | 7.91%25.71M | 7.91%25.71M | 21.45%30.78M |
| Total liabilities | -10.78%37.59M | -24.64%35.65M | -34.46%38.38M | -34.46%38.38M | -32.56%39.3M | -32.80%42.13M | -33.40%47.31M | 67.11%58.57M | 67.11%58.57M | 64.38%58.28M |
| Shareholders'equity | ||||||||||
| Share capital | 4.40%1.4B | 2.83%1.38B | 2.36%1.35B | 2.36%1.35B | 2.93%1.35B | 3.53%1.34B | 3.18%1.34B | 2.49%1.32B | 2.49%1.32B | 6.60%1.31B |
| -common stock | 4.40%1.4B | 2.83%1.38B | 2.36%1.35B | 2.36%1.35B | 2.93%1.35B | 3.53%1.34B | 3.18%1.34B | 2.49%1.32B | 2.49%1.32B | 22.70%1.31B |
| Retained earnings | -6.23%-1.31B | -6.10%-1.29B | -6.05%-1.28B | -6.05%-1.28B | -6.39%-1.26B | -6.26%-1.24B | -6.09%-1.22B | -6.12%-1.2B | -6.12%-1.2B | -6.24%-1.18B |
| Paid-in capital | 5.89%81.75M | 8.06%80.22M | 12.24%81.27M | 12.24%81.27M | 12.45%79.55M | 11.67%77.2M | 10.55%74.24M | 10.57%72.41M | 10.57%72.41M | 10.36%70.74M |
| Gains losses not affecting retained earnings | 2.34%-48.31M | 2.54%-48.37M | 4.09%-48.42M | 4.09%-48.42M | 4.16%-48.88M | 1.26%-49.47M | -0.46%-49.63M | -4.45%-50.49M | -4.45%-50.49M | -5.85%-51M |
| Total stockholders'equity | -9.09%122.45M | -20.34%114.64M | -22.53%106.02M | -22.53%106.02M | -17.99%119.34M | -12.05%134.69M | -13.22%143.92M | -19.23%136.85M | -19.23%136.85M | 11.82%145.52M |
| Total equity | -9.09%122.45M | -20.34%114.64M | -22.53%106.02M | -22.53%106.02M | -17.99%119.34M | -12.05%134.69M | -13.22%143.92M | -19.23%136.85M | -19.23%136.85M | 11.82%145.52M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data